2-Halogenoethylamines and the role of Ca 2+  in adrenergic  -receptor activation in the rat vas deferens.
D000818:Animals; D001665:Binding Sites; D001966:Bromine; D002118:Calcium / Q000494:pharmacology*; D003981:Diazoxide / Q000494:pharmacology; D003992:Dibucaine / Q000494:pharmacology; D004336:Drug Antagonism; D004347:Drug Interactions; D005021:Ethylamines / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D008744:Methylamines / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009281:Naphthalenes / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*; D009435:Synaptic Transmission / Q000187:drug effects; D013748:Tetracaine / Q000494:pharmacology; D014649:Vas Deferens / Q000187:drug effects*
D005021:Ethylamines; D008744:Methylamines; D009281:Naphthalenes; D010627:Phenethylamines; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D013748:Tetracaine; D010643:Phenoxybenzamine; D011335:Proadifen; D003992:Dibucaine; D003981:Diazoxide; D001966:Bromine; D002118:Calcium; D009638:Norepinephrine